In this large trial of severe COPD patients across 5 VA sites, a simple management program (consisting of 1 hour of education, an action plan for exacerbations, and monthly case management calls) significantly reduced COPD hospitalizations/ED visits (0.82 per patient in the control group versus 0.42 in the intervention group). The intervention group also had significant reductions in all cause hospitalizations (by 28%) and all cause ED visits (by 27%). A simple disease management program for COPD significantly reduces resource utilization (abstract)
Share This Post
One Comment
Leave A Comment
Categories
Related Posts
While spring 2020 feels like a lifetime ago, COVID-19 is still with us. Unfortunately, this winter has brought more infections, hospitalizations, and death rates that eclipse what many saw last spring. But this time, while the headlines are back about hospitals running low on PPE, ICU bed shortages, and long lines for testing, we now […]
This article is part of a series in The Hospital Leader written by members of the Division of Hospital Medicine at Dell Medical School at The University of Texas in Austin, exploring lessons learned from the coronavirus pandemic and outlining an approach for creating COVID-19 Centers of Excellence. Evidence on emerging treatments for COVID-19 has […]
While all of us see patients who smoke in their 70s or 80s, due to their limited lifespan from COPD, DM, malignancy, etc., and their expressed wishes to continue tobacco, we keep our admonitions to a minimum. We accept our patient has become learned enough through life to make their own decisions and accept whatever […]
In March 2010, researchers at Columbia University noted that they created a tissue-designed jaw bone using mesenchymal stem cells (MSCs) derived from bone marrow. MSCs naturally give rise to connective tissue such as bone and cartilage, making bone regeneration one of the most canvassed therapeutic areas for MSCs today.